Bajaj Finserv Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.5 %Nav, as on 03-11-2025

  • Previous Nav

  • Net Change on 03-11-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -0.53 20.87 18.19 1.82 8,113.59
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 4.56 27.00 20.85 1.87 6,226.82
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 2.53 24.41 19.99 1.93 3,933.26
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 -3.54 21.65 17.68 1.93 3,074.18
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 0.41 20.43 17.85 1.93 2,761.64

Fund Holdings as on 30-September-2025

  • Divi's Laboratories Limited

  • Sun Pharmaceutical Industries Limited

  • Apollo Hospitals Enterprise Limited

  • Cipla Limited

  • Fortis Healthcare Limited

  • Neuland Laboratories Limited

  • Biocon Limited

  • Aurobindo Pharma Limited October 2025 Future

  • Dr. Reddy's Laboratories Limited

  • Emcure Pharmaceuticals Limited

  • Dr. Lal Path Labs Limited

  • Piramal Pharma Limited

  • Aurobindo Pharma Limited

  • Clearing Corporation of India Ltd

  • Glenmark Pharmaceuticals Limited

  • Pfizer Limited

  • Lupin Limited

  • IPCA Laboratories Limited

  • Sanofi Consumer Healthcare India Limited

  • Zydus Wellness Limited

  • Vijaya Diagnostic Centre Limited

  • Godrej Consumer Products Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Shaily Engineering Plastics Limited

  • Medi Assist Healthcare Services Limited

  • Alkem Laboratories Limited

  • Abbott India Limited

  • Torrent Pharmaceuticals Limited

  • Rainbow Childrens Medicare Limited

  • Hindustan Unilever Limited

  • MedPlus Health Services Limited

  • Max Healthcare Institute Limited

  • Jubilant Pharmova Limited

  • Alembic Pharmaceuticals Limited

  • Mankind Pharma Limited

  • Syngene International Limited

  • AstraZeneca Pharma India Limited

  • Emami Limited

  • Marico Limited

  • PB Fintech Limited

  • Nestle India Limited

  • Neogen Chemicals Limited

  • Cohance Lifesciences Limited

  • Net Receivables / (Payables)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Household & Personal Products

  • Miscellaneous

  • Business Support

  • Consumer Food

  • Plastic Products

  • Retailing

  • Edible Oil

  • Fintech

  • Chemicals

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

View More

About Bajaj Finserv Healthcare Fund

Scheme Analysis

Bajaj Finserv Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Bajaj Finserv Mutual Fund. It was launched on 27-Dec-2024 and currently has an AUM of ₹322.41 crore. Bajaj Finserv Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Bajaj Finserv Healthcare Fund ended up ₹0.15(1.5%)yesterday to ₹9.971.

Among its top 3 holdings the fund has exposure to Divi's Laboratories Limited, and

The Bajaj Finserv Healthcare Fund is managed by Nimesh Chandan and Siddharth Chaudhary.

Fund House Contact

S. No. 208/1B, Lohagaon Viman Nagar Pune - 411014

1800-309-3900
service@bajajamc.com
020-67672550